Recent Advances in Translational Pharmacokinetics and Pharmacodynamics Prediction of Therapeutic Antibodies Using Modeling and Simulation
Therapeutic monoclonal antibodies (mAbs) have been a promising therapeutic approach for several diseases and a wide variety of mAbs are being evaluated in clinical trials. To accelerate clinical development and improve the probability of success, pharmacokinetics and pharmacodynamics (PKPD) in human...
Main Authors: | Kenta Haraya, Haruka Tsutsui, Yasunori Komori, Tatsuhiko Tachibana |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/5/508 |
Similar Items
-
Translation of Monoclonal Antibodies Pharmacokinetics from Animal to Human Using Physiologically Based Modeling in Open Systems Pharmacology (OSP) Suite: A Retrospective Analysis of Bevacizumab
by: Blaise Pasquiers, et al.
Published: (2023-08-01) -
Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis
by: Karine Rodríguez-Fernández, et al.
Published: (2022-03-01) -
Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins
by: Liming Liu
Published: (2017-04-01) -
Enhancing pharmacokinetic and pharmacodynamic properties of recombinant therapeutic proteins by manipulation of sialic acid content
by: Sean Chia, et al.
Published: (2023-07-01) -
Asprosin-neutralizing antibodies as a treatment for metabolic syndrome
by: Ila Mishra, et al.
Published: (2021-04-01)